|
N-[3-(4-methylpiperazine-1-carbonyl)-2-propan-2-yloxyphenyl]-4-oxo-1H-thieno[3,2-d]pyrimidine-7-carboxamide
|
N608685-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-cyclopropyl-3-fluoro-4-methyl-5-[3-(1-methylcyclopropyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]benzamide
|
N608684-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-cyclopropyl-3-fluoro-4-methyl-5-[3-(1-methylcyclopropyl)-[1,2,4]triazolo[4,3-a]pyridin-7-yl]benzamide
|
N608684-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[4-[2-(hydroxyamino)-2-oxoethyl]piperidin-4-yl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
|
N608675-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[4-[2-(hydroxyamino)-2-oxoethyl]piperidin-4-yl]-4-[(2-methylquinolin-4-yl)methoxy]benzamide
|
N608675-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[(2S)-3-(3-fluorophenyl)-1-oxo-1-[[(2R)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1H-indole-2-carboxamide
|
N608649-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
N-[(2S)-3-(3-fluorophenyl)-1-oxo-1-[[(2R)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1H-indole-2-carboxamide
|
N608649-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
α-NETA
|
N607554-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
α-NETA
|
N607554-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
6-nonylpyridine-2,4-diol
|
N607256-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
6-nonylpyridine-2,4-diol
|
N607256-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
6-n-octylaminouracil
|
N607255-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
6-n-octylaminouracil
|
N607255-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-(n-propyl)amino-3-nitrobenzoic acid
|
N607189-5mg
|
Moligand™ |
68740-31-8 |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-(n-propyl)amino-3-nitrobenzoic acid
|
N607189-25mg
|
Moligand™ |
68740-31-8 |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2, 4-二氧代-4-(吡啶-4-基)丁酸甲酯
|
M615751-250mg
|
≥95% |
374063-91-9 |
250mg
|
¥ 651.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2, 4-二氧代-4-(吡啶-4-基)丁酸甲酯
|
M615751-1g
|
≥95% |
374063-91-9 |
1g
|
¥ 1759.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2, 4-二氧代-4-(吡啶-4-基)丁酸甲酯
|
M615751-100mg
|
≥95% |
374063-91-9 |
100mg
|
¥ 383.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-(3-吡啶基)异噁唑-3-甲酸甲酯
|
M615727-250mg
|
≥97% |
1375064-46-2 |
250mg
|
¥ 579.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-(3-吡啶基)异噁唑-3-甲酸甲酯
|
M615727-1g
|
≥97% |
1375064-46-2 |
1g
|
¥ 1289.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
methyl (1R,2S,3S,5S)-3-(4-fluorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
|
M614843-5mg
|
Moligand™ |
50370-56-4 |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
methyl (1R,2S,3S,5S)-3-(4-fluorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
|
M614843-25mg
|
Moligand™ |
50370-56-4 |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Edg-2 receptor inhibitor 1(SAR-100842)
|
M613410-5mg
|
Moligand™, ≥98% |
1195941-38-8 |
5mg
|
¥ 1999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Edg-2 receptor inhibitor 1(SAR-100842)
|
M613410-25mg
|
Moligand™, ≥98% |
1195941-38-8 |
25mg
|
¥ 5499.9
|
期货,请咨询 |
|
0 |
阿拉丁 |